NCT01743677 - CP-690,550 Thorough QTc Study | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 26, 2007

Primary Completion Date

February 7, 2008

Study Completion Date

February 9, 2008

Conditions

Healthy

Interventions

DRUG

CP-690,550

Single dose 100 mg (5 x 20 mg tablets)

DRUG

Placebo

Single dose placebo tablets (5 tablets)

DRUG

Moxifloxacin

Single dose Avelox 400 mg tablet

Trial Locations (2)

Pfizer Clinical Research Unit, Brussels

Pfizer Clinical Research Unit, Singapore